Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sitagliptin-associated drug allergy: review of spontaneous adverse event reports.

× No keyword cloud information.

12 in total

Review 1. Diabetes mellitus and the skin.

Authors: E Makrantonaki; D Jiang; A M Hossini; G Nikolakis; M Wlaschek; K Scharffetter-Kochanek; C C Zouboulis
Journal: Rev Endocr Metab Disord Date: 2016-09 Impact factor: 6.514

Review 2. Effects of Sitagliptin on Metabolic Indices and Hormone Levels in Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials.

Authors: Lijuan Zhang; Airong Chen; Jing Lu; Liuliu Ren; Zelin Hu
Journal: Reprod Sci Date: 2022-08-12 Impact factor: 2.924

3. Inhibition of Dipeptidyl Peptidase-4 by Flavonoids: Structure-Activity Relationship, Kinetics and Interaction Mechanism.

Authors: Junkun Pan; Qiang Zhang; Chunling Zhang; Wenbo Yang; Hui Liu; Zhenzhen Lv; Jiechao Liu; Zhonggao Jiao
Journal: Front Nutr Date: 2022-05-12

4. Linagliptin-associated blistering and ulceration.

Authors: Cristina Psomadakis; Naima Shahzad; Jonathan Katz
Journal: BMJ Case Rep Date: 2017-05-31

5. Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature.

Authors: Amy Attaway; Tracey L Mersfelder; Sakshi Vaishnav; Joanne K Baker
Journal: J Dermatol Case Rep Date: 2014-03-31

6. Update on Safety Issues Related to Antihyperglycemic Therapy.

Authors: Gandahari Rosa A Carpio; Vivian A Fonseca
Journal: Diabetes Spectr Date: 2014-05

7. Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19.

Authors: Caren Droesch; Mytrang Hoang Do; Maria DeSancho; Eun-Ju Lee; Cynthia Magro; Joanna Harp
Journal: JAMA Dermatol Date: 2020-09-01 Impact factor: 10.282

8. Fixed drug eruption to sitagliptin.

Authors: Mrinal Gupta; Anish Gupta
Journal: J Diabetes Metab Disord Date: 2015-03-25

9. Drug-induced generalized skin eruption in a diabetes mellitus patient receiving a dipeptidyl peptidase-4 inhibitor plus metformin.

Authors: Kaori Nakatani; Takeshi Kurose; Takanori Hyo; Koin Watanabe; Daisuke Yabe; Terue Kawamoto; Yutaka Seino
Journal: Diabetes Ther Date: 2012-11-06 Impact factor: 2.945

Review 10. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.

Authors: Annalisa Capuano; Liberata Sportiello; Maria Ida Maiorino; Francesco Rossi; Dario Giugliano; Katherine Esposito
Journal: Drug Des Devel Ther Date: 2013-09-17 Impact factor: 4.162